Dr. J. Brantley Thrasher is Professor and the William L. Valk Chair, Department of Urology and the Co-Director of Operative Services at the University of Kansas Medical Center in Kansas City, Kansas. A native of South Carolina, he completed his Medical Degree at the Medical University of South Carolina in Charleston, South Carolina, an internship at Walter Reed Army Medical Center in Washington, D.C., and his urology residency at Fitzsimons Army Medical Center in Aurora, Colorado. He subsequently completed a urologic oncology fellowship at Duke University Medical Center. He served for three years as Program Director for the Urology Residency Program at Madigan Army Medical Center in Tacoma, Washington, and after completing his military obligation, he was appointed to his present position in 1998.
Dr. Thrasher has served on numerous national committees, including the American Joint Committee on Cancer (AJCC), as the Kansas State Representative to the Board of Directors of the South Central Section of the American Urolgical Association, as the Chair of the Fellowship Committee for the Society of Urologic Oncologyand the Public Media (previous chair), Practice Guidelines, Prostate Cancer Guidelines (vice-chair) and Audio-Visual Committees of the American Urological Association. He recently served as a mentor for the 2008 – 2009 AUA Leadership Program, is a member of the American College of Radiology Expert Advisory Panel on Prostate Cancer, a member of the Best Practice Policy Panel on Cryotherapy for the Treatment of Prostate Cancer, and the Chair of the Prostate Cancer Literature Review Panel for the American Urological Association. He is the President-Elect of the Society of Urologic Oncology, Chairman of the Metropolitan Kansas City Committee on Applicants of the American College of Surgeons, and the Past-President of the South Central Section of the American Urological Association. He was also appointed as the South Central Section Representative to the American Urological Association Board of Directors, as a Trustee of the American Board of Urology, and as a member of the Residency Review Committee for Urology. He is a Diplomate of the American Board of Urology and a Fellow of the American College of Surgeons.
Dr Thrasher has received numerous honors and awards, including America’s Top Doctors for Cancer in 2011, one of the Best Doctors in America for 2002 through 2012, by the Best Doctors Consortium, and one of America’s Top Urologists by the Consumers’ Research Council of America in 2009, 2010 and 2011. Additionally, he was chosen as one of America’s Top Physicians in Urologic Oncology by the Consumers’ Research Council of America, in 2003, 2006, 2007 and 2010. He was voted as one of the best urologists in Kansas City for 2011-2012, by KC Business Journal and U S News and World Reports.
In addition to giving over 300 presentations at local, national, and international meetings, he has written over 150 manuscripts, book chapters, and monographs in the field of urology. He has been a Visiting Professor at 24 institutions and serves as a reviewer for 6 journals. He currently serves as Coordinating Editor for Practical Reviews in Urology and Topics in Urology; Society of Urologic Oncology Specialty Society Editor for the Journal of Urology; member of the Editorial Board for Prostate Cancer and Prostate Diseases; member of the Editorial Advisory Board of the Journal of American Family Physician; an Associate Editor for the book, “The 5-Minute Urology Consult;” member of the Editorial Council for Urology Times; and Section Editor of Cancer Prevention in the Journal Seminars in Urologic Oncology.
Dr. Thrasher’s basic science research interest is in the area of prostate cancer and he is currently a co-investigator or consultant in NIH, Center for Disease Control, and Department of Defense funded research. His clinical research interests are in the area of prostate, bladder, and renal cancer, as well as reconstruction, and he serves as the principal investigator on numerous investigator initiated, industry funded, and institutionally funded protocols.